GKB Ophthalmics Limited has officially communicated to BSE Limited regarding the non-applicability of a specific SEBI circular to its operations. The company has confirmed that it does not fall under the category of "Large Corporate" as defined by regulatory guidelines.

Regulatory Compliance Notification

In a formal communication dated April 07, 2026, GKB Ophthalmics Limited addressed BSE's Department of Corporate Services to clarify its status regarding SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144. The circular, originally issued on November 26, 2018, by the Securities and Exchange Board of India, contains specific provisions that apply only to companies classified as "Large Corporates."

Company Position and Confirmation

The notification explicitly states that GKB Ophthalmics Limited does not meet the criteria for classification as a "Large Corporate" under the definitions provided in the SEBI circular. This determination means that the specific requirements and provisions outlined in the circular are not applicable to the company's operations or compliance obligations.

Administrative Details

The communication was formally signed by Pooja Dessai née Bicholkar, serving as Company Secretary of GKB Ophthalmics Limited. The document was submitted to BSE Limited for official record-keeping purposes, ensuring proper documentation of the company's regulatory status.

Regulatory Context

SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 contains specific guidelines and requirements that apply selectively based on company size and classification. By confirming its status as not being a "Large Corporate," GKB Ophthalmics has clarified its position regarding compliance obligations under this particular regulatory framework. The formal notification ensures transparency and proper regulatory alignment for the company's ongoing operations.

GKB Ophthalmics Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The Goa-based pharmaceutical company filed the mandatory documentation for the quarter ended March 31, 2026, demonstrating continued adherence to securities market regulations.

Regulatory Compliance Filing

The company submitted its certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, on April 07, 2026. Company Secretary Pooja Dessai née Bicholkar signed and submitted the documentation to BSE Limited's Department of Corporate Services.

Registrar Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, provided the confirmation certificate as the company's registrar and transfer agent. The registrar confirmed that all securities received from depository participants for dematerialisation during the quarter ended March 31, 2026, were properly processed and confirmed to the depositories.

Compliance Confirmation

The registrar confirmed several key compliance aspects in their certificate:

• Securities received for dematerialisation were confirmed or rejected within prescribed timelines
• Security certificates were properly mutilated and cancelled after verification
• Depository names were substituted in the register of members as registered owners
• All securities comprised in the certificates have been listed on stock exchanges where earlier issued securities are listed

Company Information

GKB Ophthalmics Limited operates from its facility at 16-A, Tivim Industrial Estate, Mapusa, Goa. The company, incorporated in 1981 with CIN L26109GA1981PLC000469, has been in operation since 1960 and maintains its corporate compliance through regular regulatory filings with stock exchanges and regulatory authorities.